Tailored meals delivered to heart Patients' doors in new pilot study
NCT ID NCT07251894
First seen Jun 24, 2026 · Last updated Aug 18, 2026 · Updated 4 times
Summary
This pilot study is testing whether providing medically tailored meals to heart failure patients after they leave the hospital is practical and helpful. Researchers will enroll 85 adults who are on Medicaid or Medicare and recovering from a heart failure hospitalization. The meals are designed to meet their nutritional needs, and the study will measure how many meals are successfully delivered and how patients rate the service.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- medically tailored meals
- What this could lead to
- If this works, it could show that providing tailored meals after a heart failure hospital stay helps patients recover better and reduces the chance of being readmitted.
- What could go wrong
- This is a small pilot study with only 85 people, so results may not apply to everyone. It is testing feasibility, not yet proven to improve health outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 85 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jan 2026
- Expected to finish
-
Sep 2029
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age ≥ 18 years old * Have a primary diagnosis of health failure based on ICD code I50\* with active hospitalization at time of enrollment * Must be insured by Medicaid or Medicare or dual eligible * Ability to read and speak English * Ability to provide informed consent Exclusion Criteria: * Are on hospice care or reside in an acute or skilled nursing facility * Are undergoing evaluation for advanced HF treatments including heart transplant or ventricular assist devices * Are unable to complete data collection due to cognitive decline or disability (based on the electronic health record or referring provider assessment)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Heart failure are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Penn Medicine
Philadelphia, Pennsylvania, 19104, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can an inhaler boost heart pumping in COPD patients?
- Can zapping the heart beat drugs for AF in heart failure?
- Which SGLT2 inhibitor wins? trial pits empagliflozin against dapagliflozin
- Can daily mindful breathing ease heart failure symptoms?
- Can a smartphone app keep heart failure patients out of the hospital?
- Can better training get doctors to talk about what matters most to dying veterans?